BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors

  January 12, 2026

   · 

  6 min read
• Press Releases

  Cabaletta Bio Announces 2026 Strategic Priorities

  January 12, 2026

   · 

  12 min read
• Press Releases

  Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations

  January 12, 2026

   · 

  6 min read
• Press Releases

  MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

  January 12, 2026

   · 

  6 min read
• Press Releases

  Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors

  January 12, 2026

   · 

  2 min read
• Press Releases

  Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio

  January 12, 2026

   · 

  8 min read
• Press Releases

  CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

  January 12, 2026

   · 

  9 min read
• Press Releases

  Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026

  January 12, 2026

   · 

  9 min read
• Press Releases

  Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones

  January 12, 2026

   · 

  9 min read
• Press Releases

  New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal

  January 12, 2026

   · 

  4 min read